Internal Server Error

SV Biotech - About the company

SV Biotech is a deadpooled company based in Leiden (Netherlands), founded in 2021 by Danielle Vlecken and Alexander Steinbrecher. It operates as a Provider of cell lines and production platforms for in-vitro manufacture of molecules and viruses. The company has 14 active competitors, including 2 funded and 2 that have exited. Its top competitors include companies like Multus, Nu-Tek Biosciences and Edge.

Company Details

Provider of cell lines and production platforms for in-vitro manufacture of molecules and viruses. It offers continuous cell lines that are comprised of a single cell type that can be propagated in culture and primary cell cultures areobtained from a multicellular organism. It has applicayion in research, vaccine and drug development.
Email ID
*****@sv-biotech.com, *****@sv-biotech.com
Phone Number
+31 **********
Key Metrics
Founded Year
2021
Location
Leiden, Netherlands
Stage
Deadpooled
Ranked
15th among 15 competitors
Similar Companies
Sign up to download SV Biotech's company profile

SV Biotech's funding and investors

SV Biotech has not raised any funding rounds yet.

SV Biotech's founders and board of directors

Founder? Claim Profile
The founders of SV Biotech are Danielle Vlecken and Alexander Steinbrecher. Danielle Vlecken and Alexander Steinbrecher are the CEOs of SV Biotech.
Here are the details of SV Biotech's key team members:
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

SV Biotech's Competitors and alternates

Top competitors of SV Biotech include Multus, Nu-Tek Biosciences and Edge. Here is the list of Top 10 competitors of SV Biotech, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Multus
Multus
2019, London (United Kingdom), Series A
Provider of lab-grown meat alternatives
$9.3M
45/100
2nd
Logo for Nu-Tek Biosciences
Nu-Tek Biosciences
2008, Minnetonka (United States), Unfunded
Developer of animal-free peptones and cell culture media for pharmaceutical applications
-
-
40/100
3rd
Logo for Edge
Edge
2021, New York City (United States), Unfunded
Provider of stem cell technology products for agriculture, life sciences, and cosmetics
-
-
30/100
4th
Logo for Onkologic
Onkologic
2021, Farmington (United States), Seed
Developer of NK cell culture media for cell therapies
$305K
-
25/100
5th
Logo for Metatissue
Metatissue
2018, Ilhavo (Portugal), Funding Raised
Provider of human protein-based products for cell culture, tissue engineering, and disease modeling applications
-
25/100
6th
Logo for Cellular Engineering Technologies
Cellular Engineering Technologies
2000, Coralville (United States), Early Stage
Provider of cell lines to help researchers and process development professionals
$45K
 
25/100
7th
Logo for Alt Biotech
Alt Biotech
2023, Evry Courcouronnes (France), Unfunded
Provider of cell-culture for production of non-therapeutics recombinant protiens
-
-
24/100
8th
Logo for Cell Biologics
Cell Biologics
2010, Chicago (United States), Public
Manufacturer of primary cultured cells and cell culture products
-
 
22/100
9th
Logo for Sarvoshadhi Bio
Sarvoshadhi Bio
2017, Kolhapur (India), Funding Raised
Developer of products and solutions related to cell culture media and biotechnology
-
22/100
10th
Logo for metabolIQ
metabolIQ
2022, Canada, Funding Raised
Developer of cell culture medium for pharmaceutical screening and personalized medicine
-
22/100
15th
Logo for SV Biotech
SV Biotech
2021, Leiden (Netherlands), Deadpooled
Provider of cell lines and production platforms for in-vitro manufacture of molecules and viruses
-
-
15/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on SV Biotech's competitors? Click here to see the top ones

SV Biotech's Investments and acquisitions

SV Biotech has made no investments or acquisitions yet.

FAQs about SV Biotech

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford